Alzheimer’s drug decision unsurprisingly splits experts
WASHINGTON D.C. : US regulators have approved the first ever medication for Alzheimer’s ... read more
Cogstate jumps 51pc on Alzheimer’s drug news
MELBOURNE: Shares in Cogstate, a neuroscience technology company backed by the Myer family, ... read more
Genomics outfit myDNA now considers US SPAC listing
MELBOURNE: Melbourne-founded genomics company myDNA is joining the SPAC rush as it mulls ... read more
Jefferies and Bells prepare cancer play Clarity for $250m float
MELBOURNE: Australian cancer diagnosis and treatment hopeful Clarity Pharmaceuticals has hired investment banks ... read more
